tak 603 has been researched along with ovalbumin in 1 studies
Studies (tak 603) | Trials (tak 603) | Recent Studies (post-2010) (tak 603) | Studies (ovalbumin) | Trials (ovalbumin) | Recent Studies (post-2010) (ovalbumin) |
---|---|---|---|---|---|
16 | 1 | 0 | 19,565 | 63 | 5,664 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Makino, H; Ohta, Y; Sohda, T; Yamane, M | 1 |
1 other study(ies) available for tak 603 and ovalbumin
Article | Year |
---|---|
TAK-603 selectively suppresses Th1-type cytokine production and inhibits the progression of adjuvant arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Cell Culture Techniques; Cytokines; Dose-Response Relationship, Drug; Gene Expression; Male; Mice; Mice, Inbred A; Mice, Inbred BALB C; Ovalbumin; Quinolines; Rats; Rats, Inbred Lew; RNA, Messenger; Th1 Cells; Triazoles | 1997 |